116 related articles for article (PubMed ID: 9365546)
1. Functional property, norepinephrine content and morphometric findings in human hyperplastic prostate.
Ishigooka M; Hashimoto T; Suzuki Y; Ichiyanagi O; Sasagawa I; Aoyama N; Nakada T
Prostate; 1997 Nov; 33(3):183-7. PubMed ID: 9365546
[TBL] [Abstract][Full Text] [Related]
2. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia.
Eckert RE; Schreier U; Drescher P; Madsen PO; Derouet H; Becht E; Steffens J; Ziegler M
Urol Int; 1995; 54(1):6-21. PubMed ID: 7539557
[TBL] [Abstract][Full Text] [Related]
4. Area density of smooth muscle cells and response to endothelin 1 in human hyperplastic prostate.
Ishigooka M; Yazawa H; Nakada T; Zermann DH
Eur Urol; 2000 Apr; 37(4):494-8. PubMed ID: 10765083
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia].
Sakai S; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):695-701. PubMed ID: 8709447
[TBL] [Abstract][Full Text] [Related]
6. Effect of the alpha-1 adrenoceptor blocker on tissue norepinephrine contents in human benign prostatic hyperplasia.
Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Ichiyanagi O; Nakada T
Int Urol Nephrol; 1997; 29(2):195-200. PubMed ID: 9241547
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes of histological composition in established benign prostatic hyperplasia.
Ishigooka M; Hayami S; Suzuki Y; Hashimoto T; Sasagawa I; Nakada T
Eur Urol; 1996; 29(1):85-9. PubMed ID: 8821697
[TBL] [Abstract][Full Text] [Related]
8. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
[TBL] [Abstract][Full Text] [Related]
9. Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia.
Lepor H; Gup DI; Baumann M; Shapiro E
Br J Urol; 1991 May; 67(5):493-8. PubMed ID: 1710161
[TBL] [Abstract][Full Text] [Related]
10. Relation between urethral elasticity and bladder outlet obstruction and histologic composition of the prostate in patients with benign prostatic hyperplasia.
Ichiyanagi O; Sasagawa I; Suzuki Y; Ishigooka M; Nakada T
Urology; 1999 Jun; 53(6):1149-53. PubMed ID: 10367844
[TBL] [Abstract][Full Text] [Related]
11. Contractile properties of human prostate adenomas and the development of infravesical obstruction.
Gup DI; Shapiro E; Baumann M; Lepor H
Prostate; 1989; 15(2):105-14. PubMed ID: 2477832
[TBL] [Abstract][Full Text] [Related]
12. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine contents of human prostatic hyperplasia: differences between pathological subtypes.
Ishigooka M; Hayami S; Tomaru M; Hashimoto T; Sasagawa I; Nakada T
Int Urol Nephrol; 1996; 28(1):61-6. PubMed ID: 8738621
[TBL] [Abstract][Full Text] [Related]
14. Effects of dicentrine, a novel alpha 1-adrenoceptor antagonist, on human hyperplastic prostates.
Yu SM; Ko FN; Chueh SC; Chen J; Chen SC; Chen CC; Teng CM
Eur J Pharmacol; 1994 Jan; 252(1):29-34. PubMed ID: 7512043
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
16. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle.
Shapiro E; Hartanto V; Lepor H
Prostate; 1992; 21(4):297-307. PubMed ID: 1281322
[TBL] [Abstract][Full Text] [Related]
17. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
Robert M; Costa P; Bressolle F; Mottet N; Navratil H
Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
[TBL] [Abstract][Full Text] [Related]
18. Autonomic receptors in human prostate adenomas.
Gup DI; Shapiro E; Baumann M; Lepor H
J Urol; 1990 Jan; 143(1):179-85. PubMed ID: 1688458
[TBL] [Abstract][Full Text] [Related]
19. Multidirectional contraction of human hypertrophied prostate.
Moriyama N; Miyata N; Yamaura H; Yamazaki R; Tsuchida K; Kurimoto S; Nagase Y; Ishida Y; Kawabe K
Gen Pharmacol; 1994 Nov; 25(7):1459-64. PubMed ID: 7534738
[TBL] [Abstract][Full Text] [Related]
20. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
